Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Infarction, Middle Cerebral Artery

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Infarction, Middle Cerebral Artery in 1 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, GX1
Pan, GP1
Sun, LH1
Zhang, YL1
Yang, BF1
Wang, L1

Other Studies

1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Infarction, Middle Cerebral Artery

ArticleYear
[Role of ventricular M3 receptor in arrhythmia resulted from cerebral-cardiac syndrome].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2008, Volume: 43, Issue:8

    Topics: Animals; Arrhythmias, Cardiac; Calcium; Choline; Electrocardiography; Heart Ventricles; Infarction,

2008